AC
Therapeutic Areas
Neurolief Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Relivion MG | Acute and chronic migraine | Commercial |
| Proliv™Rx | Major depressive disorder | Phase 2 |
Leadership Team at Neurolief
SD
Scott Drees
Chief Executive Officer
AD
Amit Dar
Chief Technology Officer
TB
Tony Borowicz
Chief Financial Officer
SB
Steve Beller
Chief Commercial Officer
RB
Ron Belson
Vice President, Research & Development
DL
Dganit Litinsky
Vice President, Regulatory & Quality